Richard Scolyer, Pioneering Cancer Researcher, Dies at 59
- Professor Richard Scolyer, a world-renowned cancer researcher and former Australian of the Year, died on June 8, 2026, at the age of 59.
- Scolyer established himself as a leading figure in oncology, specifically as a pathologist and expert in melanoma.
- His contributions to the field earned him significant recognition, including being named Australian of the Year.
Professor Richard Scolyer, a world-renowned cancer researcher and former Australian of the Year, died on June 8, 2026, at the age of 59. According to The Guardian, Scolyer was an eminent pathologist and melanoma expert who performed pioneering work on immunotherapy before his death following a battle with inoperable brain cancer.
What were Professor Richard Scolyer’s medical contributions?
Scolyer established himself as a leading figure in oncology, specifically as a pathologist and expert in melanoma. His work focused heavily on immunotherapy, a type of treatment that helps the immune system fight cancer.
His contributions to the field earned him significant recognition, including being named Australian of the Year. By focusing on the mechanisms of the immune system, Scolyer’s research aimed to improve outcomes for patients facing aggressive skin cancers.
When was Professor Scolyer diagnosed with cancer?
The researcher who spent his career treating others was diagnosed with inoperable brain cancer in 2023. This diagnosis marked a shift from his role as a clinician and researcher to that of a patient.
Scolyer’s transition to patienthood provided a stark contrast to his professional expertise in melanoma, as he faced a different, untreatable form of malignancy over the last three years.
How did Professor Scolyer communicate his final message?
Before reaching the final stages of his illness, Scolyer penned a statement addressed to Australians. His family shared this open letter following his death on June 8, 2026.
The letter serves as a final reflection from a man who dedicated his life to cancer research and public health. It allows his family to share his final thoughts and legacy with the public.
